Xpovio Prices, Coupons, Copay Cards & Patient Assistance
Xpovio (selinexor) is a member of the miscellaneous antineoplastics drug class and is commonly used for Diffuse Large B-Cell Lymphoma, and Multiple Myeloma.
Xpovio is available as a brand name drug only, a generic version is not yet available. View generic Xpovio availability for more details.
Xpovio prices
Oral Tablet
10 mg Xpovio oral tablet from $35,010.78 for 16 tablets
Quantity | Per unit | Price |
---|---|---|
16 (4 x 4 each) | $2,188.17 | $35,010.78 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
20 mg Xpovio oral tablet from $24,646.23 for 20 tablets
Brand | Quantity | Per unit | Price |
---|---|---|---|
Xpovio 100 mg once-weekly | 20 (4 x 5 each) | $1,232.31 | $24,646.23 |
Xpovio 40 mg once-weekly | 8 (4 x 2 each) | $3,080.78 | $24,646.23 |
Xpovio 40 mg twice-weekly | 16 (4 x 4 each) | $1,540.39 | $24,646.23 |
Xpovio 60 mg once-weekly | 12 (4 x 3 each) | $2,053.85 | $24,646.23 |
Xpovio 60 mg twice-weekly | 24 (4 x 6 each) | $1,458.78 | $35,010.78 |
Xpovio 80 mg once-weekly | 16 (4 x 4 each) | $1,540.39 | $24,646.23 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
40 mg Xpovio oral tablet from $35,010.78 for 4 tablets
Brand | Quantity | Per unit | Price |
---|---|---|---|
Xpovio 40 mg once-weekly | 4 (4 x 1 each) | $8,752.70 | $35,010.78 |
Xpovio 40 mg twice-weekly | 8 (4 x 2 each) | $4,376.35 | $35,010.78 |
Xpovio 80 mg once-weekly | 8 (4 x 2 each) | $4,376.35 | $35,010.78 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
50 mg Xpovio oral tablet from $35,010.78 for 8 tablets
Quantity | Per unit | Price |
---|---|---|
8 (4 x 2 each) | $4,376.35 | $35,010.78 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
60 mg Xpovio oral tablet from $35,010.78 for 4 tablets
Quantity | Per unit | Price |
---|---|---|
4 (4 x 1 each) | $8,752.70 | $35,010.78 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Xpovio Coupons, Copay Cards and Rebates
Xpovio offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Xpovio Co-Pay Card Program
Eligible commercially insured patients may pay as little as $5 per monthly prescription with a maximum savings of $8,000 per fill.
- Applies to:
- Xpovio
- Number of uses:
- per prescription per calendar year
Form more information phone: 844-243-7949 or Visit website
Xpovio Quick Start Program
Eligible commercially insured patients may receive medication if experiencing an insurance delay.
- Applies to:
- Xpovio
- Number of uses:
- Temporary Assistance
Form more information phone: 877-527-9493 or Visit website
Xpovio Bridge Program
Eligible commercially insured patients may receive an emergency supply of medication at no cost.
- Applies to:
- Xpovio
- Number of uses:
- Temporary Assistance
Form more information phone: 877-527-9493 or Visit website
Xpovio Dose Exchange Program
Patients whose prescribed dosage has been adjusted mid-cycle by their doctor may be eligible for up to 2 medication exchanges.
- Applies to:
- Xpovio
- Number of uses:
- Temporary Assistance
Form more information phone: 877-527-9493 or Visit website
Patient Assistance & Copay Programs for Xpovio
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Xpovio (selinexor) Tablet
More information please phone: 800-675-8416 Visit website
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Xpovio (selinexor) Tablet
More information please phone: 866-316-7263 Visit website
Provider: KaryForward Patient Support
Eligibility requirements:- Determined case by case
- Not disclosed
- Medically Necessary as determined by a Doctor
- Must be residing in the US or US territory
- Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Xpovio (selinexor) Tablet
More information please phone: 877-527-9493 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Monjuvi
Monjuvi is used for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or follicular ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Breyanzi
Breyanzi is a CAR T cell therapy for large B-cell lymphoma, CLL/SLL, follicular lymphoma, mantle ...
Kymriah
Kymriah is used to treat B-cell precursor acute lymphoblastic leukemia (ALL), large B-cell ...
Polivy
Polivy (polatuzumab vedotin-piiq) is a targeted treatment that may be used to treat diffuse large ...
Yescarta
Yescarta is used to treat large B-cell lymphoma and follicular lymphoma (FL) in adults. It is a p ...
Zynlonta
Zynlonta (loncastuximab tesirine) is used to treat relapsed or refractory diffuse large B-cell ...
Tazverik
Tazverik (tazemetostat) used for the treatment of patients with epithelioid sarcoma and follicular ...
More about Xpovio (selinexor)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
Patient resources
- Xpovio drug information
- Xpovio 40 mg once-weekly
- Xpovio 40 mg twice-weekly
- Xpovio 60 mg twice-weekly